TD Asset Management
ICPT

TD Asset Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

TD Asset Management’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-10,837
Closed -$519K – 1408
2020
Q2 		$519K Sell
10,837
-4,000
-27% -$309K ﹤0.01% 1202
2020
Q1 		$934K Sell
14,837
-1,300
-8% -$117K ﹤0.01% 1018
2019
Q4 		$2M Buy
16,137
+7,500
+87% +$671K ﹤0.01% 930
2019
Q3 		$573K Sell
8,637
-900
-9% -$60.4K ﹤0.01% 1151
2019
Q2 		$759K Buy
9,537
+337
+4% +$30.2K ﹤0.01% 1104
2019
Q1 		$1.03M Buy
+9,200
New +$1.01M ﹤0.01% 1033
2017
Q1 		– Sell
-4,000
Closed -$435K – 1429
2016
Q4 		$435K Hold
4,000
– – ﹤0.01% 1213
2016
Q3 		$658K Buy
+4,000
New +$631K ﹤0.01% 1099
2016
Q1 		– Sell
-6,600
Closed -$986K – 1389
2015
Q4 		$986K Sell
6,600
-100
-1% -$16.9K ﹤0.01% 961
2015
Q3 		$1.11M Buy
6,700
+200
+3% +$44K ﹤0.01% 902
2015
Q2 		$1.57M Sell
6,500
-400
-6% -$107K ﹤0.01% 888
2015
Q1 		$1.95M Buy
6,900
+2,600
+60% +$563K ﹤0.01% 837
2014
Q4 		$671K Hold
4,300
– – ﹤0.01% 1026
2014
Q3 		$1.02M Sell
4,300
-5,700
-57% -$1.45M ﹤0.01% 903
2014
Q2 		$2.37M Sell
10,000
-2,400
-19% -$633K ﹤0.01% 806
2014
Q1 		$4.09M Buy
+12,400
New +$4.18M 0.01% 697

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

TD Asset Management's ICPT Position: Q3 2020 in Review

TD Asset Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2020, closing a stake of 10,837 shares — an estimated $519K sold.

TD Asset Management first reported a position in ICPT in Q1 2014 and held it in 16 quarters. The position peaked at $4.09M in Q1 2014. 177 funds tracked by Wall St. Rank hold ICPT as of Q3 2020.

  • TD Asset Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • TD Asset Management sold 10,837 Intercept Pharmaceuticals, Inc. shares in Q3 2020, an estimated $519K.
  • TD Asset Management first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2014 and held it in 16 quarters.
  • TD Asset Management's Intercept Pharmaceuticals, Inc. position peaked at $4.09M in Q1 2014.
  • 177 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2020.

Based on TD Asset Management's 13F filing for Q3 2020, filed 10 Nov 2020.